BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30139996)

  • 1. Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification.
    Pathak A; Bergstrand J; Sender V; Spelmink L; Aschtgen MS; Muschiol S; Widengren J; Henriques-Normark B
    Nat Commun; 2018 Aug; 9(1):3398. PubMed ID: 30139996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.
    Hyams C; Trzcinski K; Camberlein E; Weinberger DM; Chimalapati S; Noursadeghi M; Lipsitch M; Brown JS
    Infect Immun; 2013 Jan; 81(1):354-63. PubMed ID: 23147038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H.
    Jarva H; Janulczyk R; Hellwage J; Zipfel PF; Björck L; Meri S
    J Immunol; 2002 Feb; 168(4):1886-94. PubMed ID: 11823523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human factor H with PspC of Streptococcus pneumoniae.
    Dave S; Pangburn MK; Pruitt C; McDaniel LS
    Indian J Med Res; 2004 May; 119 Suppl():66-73. PubMed ID: 15232165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.
    Duthy TG; Ormsby RJ; Giannakis E; Ogunniyi AD; Stroeher UH; Paton JC; Gordon DL
    Infect Immun; 2002 Oct; 70(10):5604-11. PubMed ID: 12228288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.
    van der Maten E; van den Broek B; de Jonge MI; Rensen KJW; Eleveld MJ; Zomer AL; Cremers AJH; Ferwerda G; de Groot R; Langereis JD; van der Flier M
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29378798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.
    Yuste J; Khandavilli S; Ansari N; Muttardi K; Ismail L; Hyams C; Weiser J; Mitchell T; Brown JS
    Infect Immun; 2010 Jan; 78(1):283-92. PubMed ID: 19884335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B.
    Melin M; Jarva H; Siira L; Meri S; Käyhty H; Väkeväinen M
    Infect Immun; 2009 Feb; 77(2):676-84. PubMed ID: 19047408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells.
    Hammerschmidt S; Agarwal V; Kunert A; Haelbich S; Skerka C; Zipfel PF
    J Immunol; 2007 May; 178(9):5848-58. PubMed ID: 17442969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization.
    Keller LE; Jones CV; Thornton JA; Sanders ME; Swiatlo E; Nahm MH; Park IH; McDaniel LS
    Infect Immun; 2013 Jan; 81(1):173-81. PubMed ID: 23115034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory Effects of Pneumococcal Extracellular Vesicles on Cellular and Humoral Host Defenses.
    Codemo M; Muschiol S; Iovino F; Nannapaneni P; Plant L; Wai SN; Henriques-Normark B
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein.
    Mohan S; Hertweck C; Dudda A; Hammerschmidt S; Skerka C; Hallström T; Zipfel PF
    Mol Immunol; 2014 Nov; 62(1):249-64. PubMed ID: 25046156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA.
    Lu L; Ma Y; Zhang JR
    J Biol Chem; 2006 Jun; 281(22):15464-74. PubMed ID: 16597618
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sharma S; Bhatnagar R; Gaur D
    Front Immunol; 2020; 11():462. PubMed ID: 32296419
    [No Abstract]   [Full Text] [Related]  

  • 17. The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion.
    Jarva H; Hellwage J; Jokiranta TS; Lehtinen MJ; Zipfel PF; Meri S
    J Immunol; 2004 Mar; 172(5):3111-8. PubMed ID: 14978117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding.
    Kotarsky H; Gustafsson M; Svensson HG; Zipfel PF; Truedsson L; Sjöbring U
    Mol Microbiol; 2001 Aug; 41(4):817-26. PubMed ID: 11532146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo binding of complement regulator factor H by Streptococcus pneumoniae.
    Quin LR; Carmicle S; Dave S; Pangburn MK; Evenhuis JP; McDaniel LS
    J Infect Dis; 2005 Dec; 192(11):1996-2003. PubMed ID: 16267773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.
    Hostetter MK
    J Infect Dis; 1986 Apr; 153(4):682-93. PubMed ID: 3950449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.